Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoids and osteoporosis

R A Adler1, C J Rosen

  • 1Division of Endocrinology and Metabolism, McGuire Veterans Affairs Medical Center, Richmond, Virginia.

Endocrinology and Metabolism Clinics of North America
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Lower Extremity Fracture Management in Chronic Spinal Cord Injury: 2022 Delphi Consensus Recommendations.

JB & JS open access·2022
Same author

Osteoporosis care amidst the prolonged pandemic.

Journal of endocrinological investigation·2021
Same author

Bone and non-contractile soft tissue changes following open kinetic chain resistance training and testosterone treatment in spinal cord injury: an exploratory study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Consensus statement from 2<sup>nd</sup> International Conference on Controversies in Vitamin D.

Reviews in endocrine & metabolic disorders·2020
Same author

IGF-1 is associated with estimated bone strength in anorexia nervosa.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Correction to: Hip fracture trends in the United States, 2002 to 2015.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018

Patients on long-term glucocorticoids face osteoporosis risk. Current prevention focuses on administration, exercise, Vitamin D, and calcium, with new therapies emerging.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Pharmacology

Background:

  • Glucocorticoids are widely used medications with significant side effects.
  • Long-term glucocorticoid therapy is a known risk factor for osteoporosis.
  • Current therapeutic strategies for glucocorticoid-induced osteoporosis (GIO) are not fully adequate.

Purpose of the Study:

  • To review the risk of osteoporosis associated with glucocorticoid use.
  • To outline current therapeutic strategies for preventing GIO.
  • To discuss emerging treatments for GIO.

Main Methods:

  • Review of existing literature on glucocorticoid-induced osteoporosis.
  • Analysis of current clinical guidelines and therapeutic approaches.
  • Discussion of novel pharmacological agents in development.

Related Experiment Videos

Main Results:

  • Patients requiring glucocorticoids for extended periods are at high risk for developing osteoporosis.
  • Current prevention strategies include careful administration, exercise, Vitamin D, and calcium supplementation.
  • Several new therapeutic agents, including bisphosphonates, growth factors, and calcitonin derivatives, are anticipated.

Conclusions:

  • Glucocorticoid therapy necessitates vigilant osteoporosis prevention.
  • While current management is essential, newer agents promise improved future prevention and treatment.
  • Ongoing research and longer-term studies are crucial for refining GIO management.